跳至主要内容
临床试验/TCTR20230124006
TCTR20230124006招募中2 期

Innovative Determination of Optimal Positive Expiratory Pressure to Increase Exercise Tolerance in COPD patients

Khon Kaen University0 个研究点目标入组 47 人开始时间: 2023年1月24日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
47

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 Years 至 80 Years(—)
性别
All

入选标准

  • 1. COPD patients GOLD stage II to IV.
  • 2. Age between 40 to 80 years old.
  • 3. Good communication, cooperation, and cognition.
  • 4. Stable COPD (without acute exacerbation in the previous 4 weeks).

排除标准

  • 1. Medical diagnosis history of cardiovascular disease or related to the contraindication of exercise.
  • 2. Home oxygen therapy (for at least 15 hours per day) or SpO2 < 88%.
  • 4. Neuromuscular and musculoskeletal disorders.
  • 5. Recent surgery.
  • 6. Spontaneous bone fracture.
  • 7. Acute lung embolism, lung infraction, or infection.
  • 8. Severe arterial hypertension (Resting of systolic >200 mmHg or diastolic of >110 mmHg).

研究者

相似试验